BOLD - Boundless Bio, Inc.
1.53
-0.080 -5.229%
Share volume: 100,940
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.61
-0.08
-0.05%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-27-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 18.278 M | |
| Selling general and admin | 4.964 M | |
| Research and development | 13.314 M | |
| Total expenses | 18.278 M | |
| Operating income | -18.278 M | |
| Ebit | -18.363 M | |
| Pretax income | -16.448 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -16.448 M | |
